HEALTH● LOWAug 17 · Aug 17, 2026, 2:34 PM
Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start
Yahoo Finance
Eli Lilly and Company's (LLY) weight-loss pill has been approved in Europe, though Novo Nordisk A/S (NVO) retains a market advantage. This marks a new development in the competitive weight-loss drug market.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH40m agoPope doing physical therapy, good recovery of lung that was operated onANSA [en]HEALTH41m agoPope doing physical therapy, good recovery of the operated lungANSA [en]HEALTH1h agoWHO boosts preparedness for Ebola-related virus in 3 countriesVanguard NigeriaHEALTH2h agoNAFDAC records 213 raids, 474 new cases in eight monthsPremium Times